Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.9 |
mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |